Nitric oxide donors for treating preterm labour

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Pharmacology

Background:

• Preterm labor necessitates tocolytic agents to delay birth and improve neonatal outcomes.
• Nitric oxide donors are explored for their uterine relaxant properties in managing preterm labor.

Purpose of the Study:

• To evaluate the efficacy of nitric oxide donors in delaying birth for threatened preterm labor.
• To assess the impact of nitric oxide donors on adverse effects and neonatal outcomes.
• To determine if nitric oxide donors offer benefits compared to placebo or other tocolytics.

Main Methods:

• Systematic review of randomized controlled trials from the Cochrane Pregnancy and Childbirth Group's Trials Register.
• Inclusion of trials involving nitric oxide donors for tocolysis in threatened preterm labor.
• Independent assessment of trial quality and data extraction by two reviewers.

Main Results:

• Twelve trials (1227 women) showed no significant prolongation of pregnancy beyond 48 hours with nitric oxide donors compared to placebo.
• Headaches were a notable adverse effect in the active treatment group.
• No significant reduction in neonatal death or serious morbidity was observed; however, one study suggested a potential benefit for serious adverse outcomes with glyceryl trinitrate.
• Compared to other tocolytics, nitric oxide donors did not demonstrate superior pregnancy prolongation but showed a reduction in most adverse effects, excluding headache.
• Infant morbidity and mortality outcomes were similar between groups.

Conclusions:

• Insufficient evidence exists to recommend the routine use of nitric oxide donors for threatened preterm labor.
• Further research is needed to clarify the role and safety of nitric oxide donors in preterm labor management.